LE WE PMID CA
Neoplasia (Oncolytic virus)2042Neubildung (Onkolytisches Virus)

17 N allylamino 17 demethoxygeldanamycin

Anoikis

Arsenic trioxide ttROS

CAR coxsackie and adenovirus receptor

Caspase8

CD31 PECAM1

CD95 FAS Apo1

Cell stress (ER stress)

Ceramide

CNS (Neoplasia Glioma)

CNS (Neoplasia Neuroblastoma)

EIF2AK3 PERK

Fenretinide

iNOS

Interferon alpha (Therapeutic use)

Interferon gamma

Interleukin10

Interleukin24 MDA7

Interleukin6

Kidney (Neoplasia RCC)

KRAS

Mammary gland (Neoplasia)

Myxoma virus

Neoplasia (Oncolytic virus)

Pancreas (Neoplasia)

PEG3 progression elevated gene 3

Prostate (Neoplasia)

RNA (MicroRNA)

Sorafenib

Stem cell (Neoplasia)

TNF alpha

TRAIL APO2

Ultrasound (Toxicity and therapeutic use)

Unfolded protein response

Vesicular stomatitis virus

2006  
1
Fighting cancer with oncolytic viruses.
[16424499] BMJ 332(7534): 170-2 (2006)
2009  
2
Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.
[19483767] Mol Ther 17(6): 934-5 (2009)
2002  
3
Cytolytic viruses as potential anti-cancer agents.
[11842243] J Gen Virol 83(Pt 3): 491-502 (2002)
2009  
4
The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
[19388908] Cell Microbiol 11(6): 889-97 (2009)
2008  
5
2006  
6
Targeting gene-virotherapy of cancer.
[16467873] Cell Res 16(1): 25-30 (2006)
2008  
7
Gene therapy progress and prospects cancer: oncolytic viruses.
[18418413] Gene Ther 15(12): 877-84 (2008)
2002  
8
2007  
9
Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
[17234747] Cancer Res 67(2): 429-32 (2007)
2005  
10
Viral oncolysis by herpes simplex virus and other viruses.
[15917655] Cancer Biol Ther 4(5): 524-31 (2005)
2002  
11
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider.
[12522445] Cancer Gene Ther 9(12): 1062-7 (2002)
2002  
12
Biosafety and product release testing issues relevant to replication-competent oncolytic viruses.
[12522444] Cancer Gene Ther 9(12): 1056-61 (2002)
2002  
13
Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
[12522441] Cancer Gene Ther 9(12): 1022-35 (2002)
2002  
14
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
[12522439] Cancer Gene Ther 9(12): 1001-12 (2002)
2002  
15
Oncolytic herpes simplex virus vectors for cancer virotherapy.
[12522436] Cancer Gene Ther 9(12): 967-78 (2002)
2007  
16
Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
[17613221] Neurosurg Focus 22(6): E4 (2007)
2006  
17
Oncolytic adenoviral therapy for glioblastoma multiforme.
[16709024] Neurosurg Focus 20(4): E19 (2006)
2000  
18
Recent developments in the virus therapy of cancer.
[10654614] Proc Soc Exp Biol Med 223(2): 118-27 (2000)
2008  
19
Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.
[18322942] World J Gastroenterol 14(9): 1321-5 (2008)
2003  
20
Getting oncolytic virus therapies off the ground.
[12892708] Cancer Cell 4(1): 7-11 (2003)
2009  
21
Newcastle disease virus as an oncolytic agent.
[20090097] Indian J Med Res 130(5): 507-13 (2009)
2011  
22
A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer.
[21709712] Acta Med Okayama 65(3): 151-62 (2011)
2003  
23
Cancer-specific viruses and the development of ONYX-015.
[14508094] Cancer Biol Ther 2(4 Suppl 1): S157-60 (2003)
2008  
24
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.
[18328829] Biochim Biophys Acta 1785(2): 217-31 (2008)
2008  
25
Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
[18437165] Cell Death Differ 15(8): 1197-210 (2008)
2010  
26
Eradication of brain tumor stem cells with an oncolytic adenovirus.
[20670595] Discov Med 10(50): 24-8 (2010)
2010  
27
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
[21034670] Discov Med 10(53): 293-304 (2010)
2010  
28
Oncolytic virotherapy for neuroblastoma.
[21122470] Discov Med 10(54): 387-93 (2010)
2004  
29
Use of replicating oncolytic adenoviruses in combination therapy for cancer.
[15328165] Clin Cancer Res 10(16): 5299-312 (2004)
2002  
30
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus.
[11857003] Br J Cancer 86(1): 5-11 (2002)
2010  
31
Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?
[20373873] Future Oncol 6(4): 619-34 (2010)
2007  
32
Viruses in the treatment of malignant glioma.
[17425484] Expert Rev Neurother 7(4): 321-4 (2007)
2006  
33
Oncolytic viruses: extreme treatment for an extreme disease.
[17661625] Future Microbiol 1(4): 351-3 (2006)
2011  
34
Translational research in oncolytic measles virotherapy: early discoveries and future steps.
[21366411] Future Microbiol 6(2): 125-8 (2011)
2010  
35
Virotherapy against malignant glioma stem cells.
[19643532] Cancer Lett 289(1): 1-10 (2010)
2010  
36
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
[20211576] Cytokine Growth Factor Rev 21(2-3): 169-75 (2010)
2010  
37
Directing systemic oncolytic viral delivery to tumors via carrier cells.
[20226717] Cytokine Growth Factor Rev 21(2-3): 119-26 (2010)
2010  
38
Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.
[20299272] Cytokine Growth Factor Rev 21(2-3): 197-203 (2010)
2010  
39
Impact of tumor microenvironment on oncolytic viral therapy.
[20399700] Cytokine Growth Factor Rev 21(2-3): 127-34 (2010)
2008  
40
Oncolytic viruses: a novel form of immunotherapy.
[18925850] Expert Rev Anticancer Ther 8(10): 1581-8 (2008)
2006  
41
[A mini-review of targeting gene-virotherapy of cancer].
[17059786] Ai Zheng 25(10): 1320-2 (2006)
2011  
42
Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.
[20948318] Cancer Biol Ther 10(12): 1290-305 (2011)
2010  
43
The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
[20574150] Cancer Biol Ther 10(3): 242-50 (2010)
2007  
44
Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
[17545625] Cancer Res 67(11): 5434-42 (2007)
2006  
45
Molecular target-based therapy of pancreatic cancer.
[16489047] Cancer Res 66(4): 2403-13 (2006)
2006  
46
Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy.
[16861924] Cell Cycle 5(14): 1531-6 (2006)
2006  
47
Targeting gene-virotherapy of cancer and its prosperity.
[17102812] Cell Res 16(11): 879-86 (2006)
2008  
48
Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene.
[18413837] Clin Cancer Res 14(8): 2450-7 (2008)
2010  
49
Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines.
[21134831] Hepatobiliary Pancreat Dis Int 9(6): 615-21 (2010)
2012  
50
Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo.
[22640485] J Exp Clin Cancer Res 31(1): 51 (2012)
2012  
51
Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
[22569271] Mol Cancer 11(1): 31 (2012)
2008  
52
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
[18723497] Mol Cancer Ther 7(8): 2528-35 (2008)
2011  
53
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
[21119025] Mol Pharmacol 79(3): 368-80 (2011)
2010  
54
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
[20179672] Mol Ther 18(6): 1130-42 (2010)
2010  
55
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.
[19888195] Mol Ther 18(2): 295-306 (2010)
2002  
56
Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
[12085234] Oncogene 21(29): 4558-66 (2002)
2005  
57
Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.
[15647352] Proc Natl Acad Sci U S A 102(4): 1059-64 (2005)
2010  
58
Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
[20872968] World J Gastroenterol 16(37): 4677-84 (2010)
2012  
59
Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.
[21995527] Acta Oncol 51(3): 285-92 (2012)
2005  
60
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
[15585417] Mol Ther 11(1): 160-72 (2005)
2005  
61
Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
[15585416] Mol Ther 11(1): 149-59 (2005)
2007  
62
Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy.
[18042930] J Natl Cancer Inst 99(23): 1739-41 (2007)
2011  
63
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.
[22059911] Chin J Cancer 30(12): 805-14 (2011)
2004  
64
Future directions: oncolytic viruses.
[14967074] Clin Lung Cancer 5(4): 226-30 (2004)
2008  
65
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
[19122384] Uirusu 58(1): 11-8 (2008)
2009  
66
Advances in oncolytic virus therapy for glioma.
[19149710] Recent Pat CNS Drug Discov 4(1): 1-13 (2009)
2010  
67
Intelligent design: combination therapy with oncolytic viruses.
[20029399] Mol Ther 18(2): 251-63 (2010)
2010  
68
Current issues and future directions of oncolytic adenoviruses.
[19935777] Mol Ther 18(2): 243-50 (2010)
2010  
69
Oncolytic viruses: an approved product on the horizon?
[20125160] Mol Ther 18(2): 233-4 (2010)
2009  
70
Herpes simplex virus oncolytic therapy for pediatric malignancies.
[19367259] Mol Ther 17(7): 1125-35 (2009)
2009  
71
Targeting cancer-initiating cells with oncolytic viruses.
[19672244] Mol Ther 17(10): 1677-82 (2009)
2009  
72
Adenoviral virotherapy for malignant brain tumors.
[19456208] Expert Opin Biol Ther 9(6): 737-47 (2009)
2008  
73
Oncolytic measles virus strains in the treatment of gliomas.
[18194077] Expert Opin Biol Ther 8(2): 213-20 (2008)
2009  
74
Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.
[19860656] Curr Gene Ther 9(5): 422-7 (2009)
2009  
75
Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.
[19860653] Curr Gene Ther 9(5): 389-95 (2009)
2006  
76
Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.
[16542009] Biol Direct 1(-): 6 (2006)
2009  
77
The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.
[19630549] Hum Gene Ther 20(10): 1119-32 (2009)
2009  
78
Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
[19169959] Curr Opin Mol Ther 11(1): 43-53 (2009)
2009  
79
Oncolytic adenoviruses targeted to cancer stem cells.
[19671759] Mol Cancer Ther 8(8): 2096-102 (2009)
2010  
80
A non-replicating oncolytic vector as a novel therapeutic tool against cancer.
[21189152] BMB Rep 43(12): 773-80 (2010)
2010  
81
The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.
[20832500] Microbes Infect 12(14-15): 1144-52 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: oncolytic virus
GG: oncolytic viral

  • Neubildung (Onkolytisches Virus)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia